Treatment of Premature Atrial Contractions During Exercise
In the absence of structural heart disease, premature atrial contractions (PACs) during exercise typically require no treatment unless symptomatic, in which case beta blockers are the first-line therapy.
Initial Evaluation
When PACs occur during exercise, a systematic evaluation is essential:
- 12-lead ECG to document the arrhythmia and assess for pre-excitation or other abnormalities
- Exercise stress testing to characterize PAC frequency, morphology, and relationship to exertion 1
- Echocardiography to exclude structural heart disease 2
- Thyroid function tests and assessment for reversible causes (caffeine, alcohol, stimulants) 3
- 24-hour Holter monitoring if PACs are frequent or symptoms occur outside of exercise 2
Risk Stratification
The clinical significance of exercise-induced PACs depends on several factors:
Higher-risk features requiring closer monitoring:
- Frequent PACs (>5 per exercise stage or >20,000/24 hours) 4, 5
- PACs in bigeminy or with blocked conduction 6
- Short runs of supraventricular tachycardia (<5 beats) 5
- Chronotropic incompetence during exercise 4
- Symptoms of palpitations, dizziness, or reduced exercise tolerance 3
Research demonstrates that frequent PACs during treadmill testing carry a 15-fold increased risk of developing atrial fibrillation (adjusted HR 15.23,95% CI: 4.59-50.56) 4. This finding challenges the traditional view that PACs are entirely benign and suggests they may represent a marker of atrial cardiomyopathy 7.
Treatment Algorithm
For Asymptomatic PACs Without Structural Heart Disease:
No treatment is required 1. These patients can participate in all competitive sports without restriction 1, 8. Annual follow-up is reasonable to monitor for development of atrial fibrillation, particularly if PAC burden is high 1.
For Symptomatic PACs Without Structural Heart Disease:
First-line: Beta blockers 3
- Most effective for exercise-related PACs
- Caution in patients with exercise-induced asthma 9
- Titrate to control symptoms while maintaining adequate exercise heart rate response
Alternative: Nondihydropyridine calcium channel blockers (diltiazem or verapamil) 3
- Consider if beta blockers are contraindicated or not tolerated
- Avoid in patients with pre-excitation patterns
Catheter ablation 5
- Reserved for drug-refractory symptomatic PACs with high burden (typically >20,000/24 hours)
- Success rate approximately 95% with low complication rates
- Significantly improves quality of life in selected patients
- After successful ablation with 3-month arrhythmia-free period, unrestricted return to competitive sports is permitted 1
For PACs With Structural Heart Disease:
Treatment should focus on the underlying cardiac condition. Rate control strategies and rhythm management depend on the specific structural abnormality present 10.
Common Pitfalls to Avoid
- Do not initiate class I or III antiarrhythmic drugs without documented sustained arrhythmia, as proarrhythmic risk outweighs benefit for isolated PACs 2
- Do not use digoxin as first-line therapy for PACs, particularly if there is any possibility of pre-excitation 11
- Do not dismiss frequent exercise-induced PACs as entirely benign—they warrant monitoring for atrial fibrillation development 4
- Do not restrict competitive sports participation in asymptomatic athletes with PACs and structurally normal hearts 1, 8
Exercise and Sports Participation
For competitive athletes with PACs and no structural heart disease, all sports are permitted 1. The presence of PACs alone does not require activity restriction. However, athletes with frequent PACs should undergo periodic reassessment (yearly) to monitor for development of sustained arrhythmias 1.
The 2025 AHA/ACC scientific statement confirms that PACs in athletes are common, with prevalence similar to sedentary individuals, and the majority are benign 8. Return to play decisions should be based on symptom severity and effects on exercise tolerance rather than PAC frequency alone 8.